Bayer Loses Major Roundup Lawsuit with $2.25 Billion Verdict

The company plans to appeal the decision, which found it negligent in failing to warn consumers about the potential carcinogenic dangers of its weedkiller's main chemical, glyphosate.

Bayer AG faces mounting pressure as it loses another major lawsuit over its Roundup weedkiller, with a Pennsylvania jury awarding $2.25 billion to a former user who blamed his cancer diagnosis on long-term exposure to the herbicide.
The plaintiff, John McKivison, claimed he developed non-Hodgkin’s lymphoma after using Roundup on his property for 20 years.
The jury found that Monsanto, which Bayer purchased in 2018, was negligent in failing to warn consumers about the carcinogenic dangers of glyphosate, the main chemical in Roundup.
Regulators in the U.S., Europe and Canada have declined to declare glyphosate a carcinogen, but the World Health Organization declared in 2015 that the chemical is 'probably carcinogenic to humans.'
Bayer intends to appeal the verdict, calling it 'unconstitutionally excessive.' The company previously agreed in 2020 to pay roughly $10 billion to tens of thousands of people who claimed that Roundup caused them to develop non-Hodgkin’s lymphoma.

The Philadelphia Inquirer